{"id":"W4402704938","doi":"10.1016/j.annonc.2024.08.1719","title":"1638P Enzalutamide (enza) with or without leuprolide in patients (pts) with high-risk biochemically recurrent (hrBCR) prostate cancer (PC): EMBARK post hoc analysis by age","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; University of British Columbia","funders":"Astellas Pharma; Pfizer","keywords":"Medicine; Enzalutamide; Prostate cancer; Oncology; Post-hoc analysis; Internal medicine; Cancer; Gynecology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001631995,0.0009775111,0.002494763,0.0003085136,0.0002454984,0.0009565062,0.0005197882,0.0007184521,0.003616747],"category_scores_gemma":[0.001495021,0.0003961406,0.002828332,0.0003767521,0.0006143481,0.001182329,0.0005019071,0.001948403,0.0003657816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005314261,"about_ca_system_score_gemma":0.0010204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001515157,"about_ca_topic_score_gemma":0.003959903,"domain_scores_codex":[0.9988992,0.0006272924,0.00004979122,0.0001838831,0.00004725391,0.000192537],"domain_scores_gemma":[0.9992585,0.0003541217,0.0001060634,0.0000619667,0.00003171331,0.000187729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.980518,0.001132108,0.005674788,0.0001284701,0.00196564,0.00005645437,0.00002797686,0.0005319898,0.001851822,0.00004513082,0.0003637868,0.007703828],"study_design_scores_gemma":[0.400143,0.4183726,0.1506337,0.0001076129,0.01478746,0.0003148533,0.0004025892,0.006722331,0.004009155,0.0006773843,0.003704877,0.0001244382],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967527,0.001104431,0.0002440239,0.0001414735,0.0001393173,0.0001331316,0.0004600876,0.00002881412,0.0009960413],"genre_scores_gemma":[0.9968311,0.0004666458,0.0002705097,0.0001581295,0.0001286956,0.0001287835,0.000528287,0.00001269604,0.001475211],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003616747,"threshold_uncertainty_score":0.01209921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03043944208096448,"score_gpt":0.3767367278549,"score_spread":0.3462972857739355,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}